Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cadila Healthcare, Torrent Reportedly In Early Merger Talks

This article was originally published in PharmAsia News

Executive Summary

Cadila Healthcare and Torrent Pharmaceuticals are said by sources to have begun negotiating a merger that would make the combination India's third-largest pharma seller, behind Dr. Reddy's Laboratories and Sun Pharmaceuticals.

You may also be interested in...



‘Open & Constructive’: Early Feedback Supports Simultaneous Scientific Advice In Europe

A European pilot project that lets drug companies developing innovative products receive scientific advice from two EU member states at the same time is proving its worth during the pandemic.

Australia’s TGA Seeks Feedback on Data Matrix Code Labelling

The Australian Therapeutic Goods Administration is consulting on a draft standard for data matrix codes on the labels of certain medicines.

Amgen Settles On Bevacizumab And Trastuzumab

Amgen has filed to settle on undisclosed terms patent-infringement litigation involving both its Kanjinti and Mvasi biosimilars, having previously seen originator Genentech fail multiple times to block commercial sales of the products that were launched ‘at risk’.

Topics

UsernamePublicRestriction

Register

PS140995

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel